UPDATE : Monday, September 7, 2020
상단여백
Genexine to start P1 trial of Covid-19 treatment in US by Lee Han-soo 2020-06-11 16:26
Greater Seoul remains hot spot of Covid-19 infections by Lee Han-soo 2020-06-11 12:08
'Imfinzi changed treatment paradigm for non-resectable NSCLC' by Lee Han-soo 2020-06-10 17:58
Myongji Hospital to develop AI-based Covid-19 detection kit in 3-way project by Lee Han-soo 2020-06-10 16:07
New virus cases rise back amid unrelenting cluster infections in greater Seoul by Lee Han-soo 2020-06-10 11:49
라인
Baekje to distribute Leo Pharma's dermatology products by Lee Han-soo 2020-06-09 16:49
LegoChem licenses in Covid-19 treatment candidates by Lee Han-soo 2020-06-09 16:48
Researchers find recurrence cause for pemphigus by Lee Han-soo 2020-06-09 13:37
Korean, US firms in legal battle over Covid-19 vaccine know-how by Lee Han-soo 2020-06-08 21:28
[Reporter's Notebook] Korean firms found something missing in ‘virtual’ ASCO 2020 by Lee Han-soo 2020-06-08 16:54
라인
Environmental chemicals causing chronic kidney disease identified by Lee Han-soo 2020-06-08 15:14
IVI ties up with SNUH for clinical trial of Covid-19 vaccine by Lee Han-soo 2020-06-04 17:04
[ASCO 2020 ⑤] Lunit opens possibility of personalized cancer treatment with AI platform by Lee Han-soo 2020-06-04 16:25
MedPacto to test Vactosertib for treating NSCLC by Lee Han-soo 2020-06-04 12:43
Dupixent to provide new treatment options for asthma patients by Lee Han-soo 2020-06-03 17:54
라인
New plasma-based method found to treat refractory blood cancer by Lee Han-soo 2020-06-03 16:29
Treating helicobacter bacteria after gastric cancer surgery lifts survival rate by Lee Han-soo 2020-06-03 16:05
CDK 4/6 inhibitor market to heat up on insurance benefits by Lee Han-soo 2020-06-02 17:13
[ASCO 2020 ②] GC confirms safety, efficacy of anti-EGFR monoclonal antibody by Lee Han-soo 2020-06-02 11:20
[ASCO 2020 ①] Samsung Bioepis’ anticancer biosimilar shows equal quality to original drug by Lee Han-soo 2020-06-01 16:14
여백
여백
여백
Back to Top